Twice-daily radiation linked to better quality of life in lung cancer trial
Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for ...
30 Aug 00:30 · Medical Xpress